MCL-1, BCL-XL and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment
Mariusz L. Hartman(Medical University of Lodz), Małgorzata Czyż(Medical University of Lodz)
Cited by 11
Related Papers
Vemurafenib and trametinib reduce expression of CTGF and IL-8 in V600EBRAF melanoma cells
|Laboratory Investigation|2017|32
Physiologically Relevant Oxygen Concentration (6% O2) as an Important Component of the Microenvironment Impacting Melanoma Phenotype and Melanoma Response to Targeted Therapeutics In Vitro
|International Journal of Molecular Sciences|2019|24
17-Aminogeldanamycin Inhibits Constitutive Nuclear Factor-Kappa B (NF-κB) Activity in Patient-Derived Melanoma Cell Lines
|International Journal of Molecular Sciences|2020|17